These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36037830)

  • 1. Essen Stroke Risk Score Predicts Clinical Outcomes in Heart Failure Patients with Preserved Ejection Fraction: Evidence from the TOPCAT trial.
    Zhu W; Cao Y; Ye M; Huang H; Wu Y; Ma J; Dong Y; Liu X; Liu C; Lip GYH
    Thromb Haemost; 2023 Jan; 123(1):85-96. PubMed ID: 36037830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHA2DS2-VASc and ATRIA Scores and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
    Zhu W; Wu Y; Zhou Y; Liang W; Xue R; Wu Z; Dong Y; Liu C
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):763-772. PubMed ID: 32583288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for predicting incident atrial fibrillation in heart failure with preserved ejection fraction patients.
    Wu Y; Xie Z; Liang W; Xue R; Wu Z; Wu D; He J; Zhu W; Liu C
    ESC Heart Fail; 2021 Apr; 8(2):1369-1377. PubMed ID: 33506643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of B-Type Natriuretic Peptide for Predicting the Risk of Stroke in Patients With Heart Failure With Preserved Ejection Fraction.
    Liu X; Abudukeremu A; Yu P; Cao Z; Sun R; Wu M; Chen Z; Ma J; Zhu W; Chen Y; Zhang Y; Wang J
    J Am Heart Assoc; 2022 Aug; 11(15):e024302. PubMed ID: 35904188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of diabetic retinopathy on prognosis of patients with heart failure with preserved ejection fraction.
    Yang Y; Zhou Y; Cao Y; Dong Y; Liu C; Zhu W
    Nutr Metab Cardiovasc Dis; 2022 Jul; 32(7):1711-1718. PubMed ID: 35606228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial Infarction in Heart Failure With Preserved Ejection Fraction: Pooled Analysis of 3 Clinical Trials.
    Cunningham JW; Vaduganathan M; Claggett BL; John JE; Desai AS; Lewis EF; Zile MR; Carson P; Jhund PS; Kober L; Pitt B; Shah SJ; Swedberg K; Anand IS; Yusuf S; McMurray JJV; Pfeffer MA; Solomon SD
    JACC Heart Fail; 2020 Aug; 8(8):618-626. PubMed ID: 32387067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction.
    Sandesara PB; Hammadah M; Samman-Tahhan A; Kelli HM; O'Neal WT
    Clin Cardiol; 2017 Sep; 40(9):692-696. PubMed ID: 28444995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of liver fibrosis scores for predicting mortality and morbidity in heart failure with preserved ejection fraction.
    Cao Y; Guo S; Dong Y; Liu C; Zhu W
    ESC Heart Fail; 2023 Jun; 10(3):1771-1780. PubMed ID: 36864701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist).
    Hegde SM; Claggett B; Shah AM; Lewis EF; Anand I; Shah SJ; Sweitzer NK; Fang JC; Pitt B; Pfeffer MA; Solomon SD
    Circulation; 2017 Sep; 136(11):982-992. PubMed ID: 28637881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic risk in patients with heart failure with preserved ejection fraction: A post hoc analysis of the TOPCAT data.
    He X; Dong B; Liang W; Wu Y; Chen Y; Dong Y; He J; Liu C
    Atherosclerosis; 2022 Mar; 344():1-6. PubMed ID: 35101783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C
    Liang W; Wu Y; Xue R; Wu Z; Wu D; He J; Dong Y; Lip GYH; Zhu W; Liu C
    BMC Med; 2021 Feb; 19(1):44. PubMed ID: 33596909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial.
    Lewis EF; Claggett B; Shah AM; Liu J; Shah SJ; Anand I; O'Meara E; Sweitzer NK; Rouleau JL; Fang JC; Desai AS; Retta TM; Solomon SD; Heitner JF; Stamos TD; Boineau R; Pitt B; Pfeffer MA
    Circ Heart Fail; 2018 Mar; 11(3):e004457. PubMed ID: 29664406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial.
    Myhre PL; Vaduganathan M; Claggett BL; Anand IS; Sweitzer NK; Fang JC; O'Meara E; Shah SJ; Desai AS; Lewis EF; Rouleau J; Pitt B; Pfeffer MA; Solomon SD
    JAMA Cardiol; 2018 Oct; 3(10):1000-1005. PubMed ID: 30140899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine Learning Prediction of Mortality and Hospitalization in Heart Failure With Preserved Ejection Fraction.
    Angraal S; Mortazavi BJ; Gupta A; Khera R; Ahmad T; Desai NR; Jacoby DL; Masoudi FA; Spertus JA; Krumholz HM
    JACC Heart Fail; 2020 Jan; 8(1):12-21. PubMed ID: 31606361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate and the risk of adverse outcomes in patients with heart failure with preserved ejection fraction.
    O'Neal WT; Sandesara PB; Samman-Tahhan A; Kelli HM; Hammadah M; Soliman EZ
    Eur J Prev Cardiol; 2017 Jul; 24(11):1212-1219. PubMed ID: 28482692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Minimal Left Atrial Volume in Heart Failure With Preserved Ejection Fraction.
    Shin SH; Claggett B; Inciardi RM; Santos ABS; Shah SJ; Zile MR; Pfeffer MA; Shah AM; Solomon SD
    J Am Heart Assoc; 2021 Aug; 10(15):e019545. PubMed ID: 34325519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction.
    Shen L; Jhund PS; Anand IS; Carson PE; Desai AS; Granger CB; Køber L; Komajda M; McKelvie RS; Pfeffer MA; Solomon SD; Swedberg K; Zile MR; McMurray JJV
    Clin Res Cardiol; 2021 Aug; 110(8):1234-1248. PubMed ID: 33301080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Santos AB; Roca GQ; Claggett B; Sweitzer NK; Shah SJ; Anand IS; Fang JC; Zile MR; Pitt B; Solomon SD; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002763. PubMed ID: 27056882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction.
    Segar MW; Patel RB; Patel KV; Fudim M; DeVore AD; Martens P; Hedayati SS; Grodin JL; Tang WHW; Pandey A
    JAMA Cardiol; 2021 Jan; 6(1):68-77. PubMed ID: 33206129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial.
    Anand IS; Claggett B; Liu J; Shah AM; Rector TS; Shah SJ; Desai AS; O'Meara E; Fleg JL; Pfeffer MA; Pitt B; Solomon SD
    JACC Heart Fail; 2017 Apr; 5(4):241-252. PubMed ID: 28359411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.